Adiponectin
- 1 February 2006
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (2), 235-236
- https://doi.org/10.1161/01.atv.0000200222.55680.df
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Adiponectin Acts as an Endogenous Antithrombotic FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- IN FOCUS: Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistanceJournal of Thrombosis and Haemostasis, 2005
- Adipose Tissue, Inflammation, and Cardiovascular DiseaseCirculation Research, 2005
- Adipokines: molecular links between obesity and atheroslcerosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- The effects of PPAR-? ligand pioglitazone on platelet aggregation and arterial thrombus formationCardiovascular Research, 2005
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from AtherosclerosisPublished by Elsevier BV ,2003
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996